35068466|t|Dendrobium nobile Lindl. Alkaloids Ameliorate Abeta25-35-Induced Synaptic Deficits by Targeting Wnt/beta-Catenin Pathway in Alzheimer's Disease Models.
35068466|a|BACKGROUND: Dendrobium nobile Lindl. alkaloids (DNLA) are effective in ameliorating cognitive deficit in SAMP8, AbetaPP/PS1, and LPS-induced AD animal models, and prevented Abeta-induced synaptic degeneration in cultured hippocampal neurons. However, the underlying mechanisms remain unexplored. OBJECTIVE: This study investigated the protective effects of DNLA on synaptic damage in an Abeta25-35-induced rat AD model, in primary cortical neuron cultures, and in PC12 cells transfected with human AbetaPP695, focusing on the Wnt/beta-catenin pathway. METHODS: Sprague-Dawley rats received a single Abeta25-35 injection (10mug) into the bilateral hippocampi. DNLA (40 and 80 mg/kg/d) was intragastrically administrated 7 days prior to Abeta injection and continued for 28 days. The spatial learning and memory, synaptic morphology, synapse-related proteins, and Wnt signaling components GSK3beta and beta-catenin phosphorylation were evaluated. Rat primary cortical neuron cultures and AbetaPP695-PC12 cells were used to evaluate axonal mitochondria distribution, reactive oxygen species production, amyloidogenesis, and Wnt pathway in the protection. RESULTS: DNLA ameliorated Abeta-induced cognitive impairment, increased the number of synapses, elevated the postsynaptic density thickness and expression of synapsin and PSD95 in the hippocampus, and suppressed Abeta-mediated GSK3beta activity and the beta-catenin phosphorylation. In primary neurons and AbetaPP695-PC12 cells, DNLA restored Abeta25-35 induced mitochondrial dysfunction and inhibited reactive oxygen species production and amyloidogenesis. Furthermore, the Wnt/beta-catenin pathway inhibitor Dkk-1 blocked the effect of DNLA on the expression of Abeta1-42 and PSD95. CONCLUSION: DNLA rescued Abeta-mediated synaptic and mitochondrial injury and inhibited amyloidogenesis in vivo and in vitro, probably through the activation of Wnt/beta-catenin signaling pathway to protect synaptic integrity.
35068466	0	23	Dendrobium nobile Lindl	Species	94219
35068466	25	34	Alkaloids	Chemical	MESH:D000470
35068466	96	99	Wnt	Gene	114487
35068466	100	112	beta-Catenin	Gene	84353
35068466	124	143	Alzheimer's Disease	Disease	MESH:D000544
35068466	164	187	Dendrobium nobile Lindl	Chemical	-
35068466	189	198	alkaloids	Chemical	MESH:D000470
35068466	200	204	DNLA	Chemical	-
35068466	236	253	cognitive deficit	Disease	MESH:D003072
35068466	257	262	SAMP8	CellLine	CVCL:4564
35068466	264	271	AbetaPP	Gene	54226
35068466	272	275	PS1	Gene	29192
35068466	281	284	LPS	Chemical	MESH:D008070
35068466	293	295	AD	Disease	MESH:D000544
35068466	325	330	Abeta	Gene	54226
35068466	348	360	degeneration	Disease	MESH:D009410
35068466	509	513	DNLA	Chemical	-
35068466	517	532	synaptic damage	Disease	MESH:D012183
35068466	558	561	rat	Species	10116
35068466	562	564	AD	Disease	MESH:D000544
35068466	616	620	PC12	CellLine	CVCL:0481
35068466	644	649	human	Species	9606
35068466	678	681	Wnt	Gene	114487
35068466	682	694	beta-catenin	Gene	1499
35068466	728	732	rats	Species	10116
35068466	811	815	DNLA	Chemical	-
35068466	887	892	Abeta	Gene	54226
35068466	1014	1017	Wnt	Gene	114487
35068466	1039	1047	GSK3beta	Gene	84027
35068466	1052	1064	beta-catenin	Gene	84353
35068466	1097	1100	Rat	Species	10116
35068466	1138	1148	AbetaPP695	CellLine	CVCL:CX57
35068466	1149	1153	PC12	CellLine	CVCL:0481
35068466	1216	1239	reactive oxygen species	Chemical	MESH:D017382
35068466	1252	1267	amyloidogenesis	Disease	
35068466	1273	1276	Wnt	Gene	114487
35068466	1313	1317	DNLA	Chemical	-
35068466	1330	1335	Abeta	Gene	54226
35068466	1344	1364	cognitive impairment	Disease	MESH:D003072
35068466	1475	1480	PSD95	Gene	29495
35068466	1516	1521	Abeta	Gene	54226
35068466	1531	1539	GSK3beta	Gene	84027
35068466	1557	1569	beta-catenin	Gene	84353
35068466	1610	1620	AbetaPP695	CellLine	CVCL:CX57
35068466	1621	1625	PC12	CellLine	CVCL:0481
35068466	1633	1637	DNLA	Chemical	-
35068466	1666	1691	mitochondrial dysfunction	Disease	MESH:D028361
35068466	1706	1729	reactive oxygen species	Chemical	MESH:D017382
35068466	1745	1760	amyloidogenesis	Disease	
35068466	1779	1782	Wnt	Gene	114487
35068466	1783	1795	beta-catenin	Gene	84353
35068466	1814	1819	Dkk-1	Gene	293897
35068466	1842	1846	DNLA	Chemical	-
35068466	1882	1887	PSD95	Gene	29495
35068466	1901	1905	DNLA	Chemical	-
35068466	1914	1919	Abeta	Gene	54226
35068466	1942	1962	mitochondrial injury	Disease	MESH:D028361
35068466	1977	1992	amyloidogenesis	Disease	
35068466	2050	2053	Wnt	Gene	114487
35068466	2054	2066	beta-catenin	Gene	84353
35068466	Negative_Correlation	293897	84353
35068466	Association	114487	84027
35068466	Positive_Correlation	MESH:D003072	54226
35068466	Negative_Correlation	MESH:D000470	MESH:D000544
35068466	Association	114487	84353
35068466	Association	MESH:D000544	114487
35068466	Association	293897	29495
35068466	Association	54226	84353
35068466	Positive_Correlation	MESH:D008070	MESH:D000544
35068466	Negative_Correlation	MESH:D000470	MESH:D003072
35068466	Negative_Correlation	MESH:D000470	MESH:D009410
35068466	Association	MESH:D028361	114487
35068466	Association	MESH:D028361	84353
35068466	Association	54226	84027
35068466	Association	MESH:D028361	54226
35068466	Positive_Correlation	MESH:D009410	54226
35068466	Association	MESH:D000470	84353
35068466	Association	MESH:D000470	114487

